Analyst Research Report Snapshot


Shionogi & Co., Ltd.




MarketLine (a Datamonitor Company)


08 Apr 2014





Companies referenced:


Available for Immediate Download

Shionogi & Co., Ltd. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Shionogi & Co., Ltd. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Shionogi & Co., Ltd. in the form of a SWOT analysis - An in-depth view of the business model of Shionogi & Co., Ltd. including a breakdown and examination of key business segments - Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Shionogi & Co., Ltd. - Intelligence on Shionogi & Co., Ltd.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Shionogi & Co., Ltd., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Shionogi & Co. (Shionogi or 'the group') is engaged in the research, development, manufacture, and marketing of ethical drugs, over-the-counter drugs and diagnostic products. Shionogi primarily operates in Japan, Europe and North America. It is headquartered in Osaka, Japan, and employed 6,132 people as of March 31, 2012. The group recorded revenues of JPY267,275 million ($3,394.4 million*) during the financial year ended March 2012 (FY2012), a decrease of 5.3% over FY2011. The operating profit of the group was JPY47,003 million ($596.9 million*) in FY2012, an increase of 0.2% over FY2011. The net profit was JPY27,102 million ($344.2 million*) in FY2012, an increase of 35.3% over FY2011. *Calculated using a constant conversion rate of JPY1 = $0.0127 for the year ended March 31, 2012. Reasons to Purchase: - Gain understanding of Shionogi & Co., Ltd. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Shionogi & Co., Ltd. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Shionogi & Co., Ltd.’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.